2023
Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project
DOSTALEK, Lukas, Klára BENEŠOVÁ, Jaroslav KLAT, Sarah H KIM, Henrik FALCONER et. al.Základní údaje
Originální název
Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project
Autoři
DOSTALEK, Lukas (203 Česká republika), Klára BENEŠOVÁ (203 Česká republika, domácí), Jaroslav KLAT (203 Česká republika), Sarah H KIM, Henrik FALCONER, Jan KOSTUN (203 Česká republika), dos Reis RICARDO, Ignacio ZAPARDIEL, Fabio LANDONI, David Isla ORTIZJ, Luc R C W VAN LONKHUIJZEN, Aldo LOPEZ, Diego ODETTO, Martina BORCINOVA, Jiří JARKOVSKÝ (203 Česká republika, domácí), Sahar SALEHI, Kristyna NEMEJCOVA, Sylva BAJSOVA (203 Česká republika), Kay J PARK, Veronika JAVURKOVA (203 Česká republika), Nadeem R ABU-RUSTUM, Pavel DUNDR (203 Česká republika) a David CIBULA (203 Česká republika, garant)
Vydání
Gynecologic Oncology, SAN DIEGO, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2023, 0090-8258
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30214 Obstetrics and gynaecology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.700 v roce 2022
Kód RIV
RIV/00216224:14110/23:00130194
Organizační jednotka
Lékařská fakulta
UT WoS
000891635900010
Klíčová slova anglicky
Micrometastasis; Cervical cancer; Low volume metastasis; Disease-free survival; Histopathological ultrastaging; Isolated tumor cells; Sentinel lymph node; Macrometastasis; Classification; Prognosis
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 18. 1. 2023 13:38, Mgr. Tereza Miškechová
Anotace
V originále
Background. In cervical cancer, presence of lymph-node macrometastases (MAC) is a major prognostic factor and an indication for adjuvant treatment. However, since clinical impact of micrometastases (MIC) and isolated tumor-cells (ITC) remains controversial, we sought to identify a cut-off value for the metastasis size not associ-ated with negative prognosis.Methods. We analyzed data from 967 cervical cancer patients (T1a1L1-T2b) registered in the SCCAN (Surveil-lance in Cervical CANcer) database, who underwent primary surgical treatment, including sentinel lymph-node (SLN) biopsy with pathological ultrastaging. The size of SLN metastasis was considered a continuous variable and multiple testing was performed for cut-off values of 0.01-1.0 mm. Disease-free survival (DFS) was compared be-tween N0 and subgroups of N1 patients defined by cut-off ranges.Results. LN metastases were found in 172 (18%) patients, classified as MAC, MIC, and ITC in 79, 54, and 39 pa-tients, respectively. DFS was shorter in patients with MAC (HR 2.20, P = 0.003) and MIC (HR 2.87, P < 0.001), while not differing between MAC/MIC (P = 0.484). DFS in the ITC subgroup was neither different from N0 (P = 0.127) nor from MIC/MAC subgroups (P = 0.449). Cut-off analysis revealed significantly shorter DFS com-pared to N0 in all subgroups with metastases >= 0.4 mm (HR 2.311, P = 0.04). The significance of metastases <0.4 mm could not be assessed due to limited statistical power (<80%). We did not identify any cut-off for the size of metastasis with significantly better prognosis than the rest of N1 group.Conclusions. In cervical cancer patients, the presence of LN metastases >= 0.4 mm was associated with a signif-icant negative impact on DFS and no cut-off value for the size of metastasis with better prognosis than N1 was found. Traditional metastasis stratification based on size has no clinical implication.